# Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma

> **NCT05411926** · — · UNKNOWN · sponsor: **Beijing Tsinghua Chang Gung Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Acute Rejection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05411926
- **Lead sponsor:** Beijing Tsinghua Chang Gung Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-17
- **Primary completion:** 2023-03
- **Final completion:** 2023-09
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05411926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05411926, "Effect of PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on Acute Rejection After Liver Transplantation in Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05411926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*